Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"PBPK modeling and simulation"”.

  1. Predicting Human Fetal Drug Exposure to Placental P-glycoprotein Substrates by PBPK Modeling and Simulation

    … women take at least one drug during pregnancy and about 50% during the first trimester when the fetus is the most vulnerable to drug toxicity (Scaffidi, Mol, & Keelan, 2017). To inform fetal risk and to optimize maternal-fetal drug therapy, it is important to measure or predict fetal drug …

    washington Repository record for Predicting Human Fetal Drug Exposure to Placental P-glycoprotein Substrates by PBPK Modeling and Simulation (opens in a new tab)

  2. Predicting maternal-fetal cannabinoid exposure during pregnancy using physiologically-based pharmacokinetic modeling and simulation

    … is associated with reduced fetal growth and subtle but persistent neurodevelopmental effects. It is not possible to establish the independent risk associated with maternal cannabis use via prospective clinical studies due to ethical considerations. In vitro and animal studies identified …

    washington Repository record for Predicting maternal-fetal cannabinoid exposure during pregnancy using physiologically-based pharmacokinetic modeling and simulation (opens in a new tab)

  3. Development and Application of Mechanistic IVIVE-Based Physiologically Based Pharmacokinetic (PBPK) Models for Predicting Drug Disposition: Case Studies of Miltefosine, Genistein, and PFOA

    Physiologically based pharmacokinetic (PBPK) modeling, although first introduced in 1937, has since evolved into an indispensable tool for predicting drug disposition across species by integrating in vitro and in vivo data within a mathematical mechanistic framework. This approach facilitates a …

    ku Repository record for Development and Application of Mechanistic IVIVE-Based Physiologically Based Pharmacokinetic (PBPK) Models for Predicting Drug Disposition: Case Studies of Miltefosine, Genistein, and PFOA (opens in a new tab)

  4. Predicting Maternal-Fetal Disposition of Drugs Using In Vitro and In Silico Tools

    During pregnancy, physiological and ADMET changes in the maternal-fetal dyad can significantly alter drug pharmacokinetics (PK) in the mother and may necessitate dosing regimen adjustments. One clinically important example is CYP3A. Its activity increases by ~2-fold during the third trimester (T3) …

    washington Repository record for Predicting Maternal-Fetal Disposition of Drugs Using In Vitro and In Silico Tools (opens in a new tab)

  5. Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation in the Development of Spectinamides, a Novel Class of Anti-Tuberculosis Agents

    … control the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of tuberculosis, which still remains an important public health challenge globally. Recently, spectinamides have emerged as a novel class of anti-tuberculosis agents that overcomethe native drug efflux. …

    tenn-hsc Repository record for Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation in the Development of Spectinamides, a Novel Class of Anti-Tuberculosis Agents (opens in a new tab)